The FDA on August 31, 2021, approved BRUKINSA® for adult patients with Waldenström’s Macroglobulinemia (WM). BRUKINSA® is a product of BeiGene.
Other Pages – Top Ad
Advertisement
Leaving ChemoPrescribe
You are now leaving ChemoPrescribe website.
To return to the website, click on the back arrow on your browser.